Mark Shoemaker
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Pharmacology top 5%
- Flavonoids in Medical Research
Papers in
-
- Flavonoids in Medical Research 2
-
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Isaac V. Cohen (7 shared papers)Michael J. Campbell (3 shared papers)Michael Jay Campbell (1 shared paper)Emma Shtivelman (4 shared papers)Mary Ann Tagliaferri (3 shared papers)Anjali S. Kumar (1 shared paper)Lance A. Liotta (1 shared paper)Christopher C. Benz (1 shared paper)
- Journals
- Cancer Research (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Phytotherapy Research (1 paper)Cancer Biology & Therapy (1 paper)Journal of Ethnopharmacology (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Mark Shoemaker
10 papers receiving 929 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 290
- Pharmacology 208
- Pharmacology 72
- Complementary and alternative medicine 61
- Toxicology 23
Countries citing papers authored by Mark Shoemaker
This map shows the geographic impact of Mark Shoemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shoemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shoemaker more than expected).
Fields of papers citing papers by Mark Shoemaker
This network shows the impact of papers produced by Mark Shoemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shoemaker. The network helps show where Mark Shoemaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Shoemaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 305 | |
| 2 | 2005 | 205 | |
| 3 | Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy. | 1986 | 90 |
| 4 | 2006 | 88 | |
| 5 | 2009 | 76 | |
| 6 | 2004 | 76 | |
| 7 | Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. | 2003 | 64 |
| 8 | 2008 | 41 | |
| 9 | 2009 | 33 | |
| 10 | 2013 | 8 |
About Mark Shoemaker
Mark Shoemaker is a scholar working on Pharmacology, Cancer Research, Molecular Biology, Immunology and Allergy and Biotechnology, having authored 10 papers that have together received 986 indexed citations. Recurring topics across this work include Flavonoids in Medical Research (2 papers), Cancer, Lipids, and Metabolism (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Natural product bioactivities and synthesis (2 papers), Cell Adhesion Molecules Research (1 paper), Lipoproteins and Cardiovascular Health (1 paper), Phytochemistry and biological activity of medicinal plants (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Cancer Research (290 citations), Pharmacology (208 citations), Pharmacology (72 citations), Complementary and alternative medicine (61 citations) and Toxicology (23 citations). Mark Shoemaker has collaborated with scholars based in United States and Canada. Frequent co-authors include Isaac V. Cohen, Michael J. Campbell, Michael Jay Campbell, Emma Shtivelman, Mary Ann Tagliaferri, Anjali S. Kumar, Lance A. Liotta, Christopher C. Benz, Emanuel F. Petricoin and Corina Marx. Their work appears in journals such as Cancer Research, Bioorganic & Medicinal Chemistry Letters, Phytotherapy Research, Cancer Biology & Therapy and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.